In this edition of What We’re Reading, Science Speaks highlights the following articles and news pieces: Community-based Voluntary Counseling and Testing Ups HIV Testing Rates; Effectiveness of Four-Drug TB Treatment Confirmed; TB Discovery Paves the Way for Drugs that Prevent Lung Destruction, Antiretroviral Therapy and the Control of HIV Associated TB – Will ART Do It?; and Updates from the PEPFAR Annual Meeting in South Africa.
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]